Primary Recipient

OREGON HEALTH & SCIENCE UNIVERSITY

Amount

$132,917.00

Award Date

8/01/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Most patients with early chronic myeloid leukemia (CML) achieve durable responses to treatment with imatinib, a specific inhibitor of BCR-ABL, the tyrosine kinase responsible for CML. However, relapse is frequent in patients with advanced disease and usua

Recipients Connected to Award

Recipient	Role	Amount
UNIVERSITY OF UTAH, THE	Sub-recipient	$116,578.00
OREGON HEALTH & SCIENCE UNIVERSITY	Primary recipient	$16,339.00